Why Pristyn Care is losing favour with doctors and hospitals
Accused of pushing for unnecessary surgical procedures, the health tech startup now faces a backlash and the prospect of regulatory action.

Why read this story?
Editor's note: On a Monday morning earlier this year, A was scheduled to perform haemorrhoid surgery on a 50-year-old man. For a few weeks, the patient had been experiencing bleeding and painful bowel movements, and he had eventually reached out to the online surgery care platform, Pristyn Care, for treatment. In initial consultations with the Pristyn Care team, for whom proctology cases are a regular affair, the patient had been told he’d need surgery. But a day before the procedure, during a pre-op consultation with the patient, A realized that surgery wasn’t really required and that the problem could be treated with medication. It should have been a simple decision for the doctor, who is in his early 40s and has been practising for about 15 years. Instead, he was at a crossroads. Cancelling the surgery would jeopardize his ties with the company. It had only been a couple of months since he’d joined Pristyn Care, during which he’d conducted about 10 procedures. The brief when he joined was clear: The more surgeries he’d perform, the more leads he would get. The …
More in Internet
You may also like
Sanchar Saathi was never the cure
Even though the government of India did a U-turn on the mandatory pre-installation of the anti-fraud app on all mobile phones sold or imported in the country, the larger problem of petty cybercrime remains grim.
FabHotels pivoted to corporate travel for survival. Can it grow?
The challenges of running a budget hotel chain in India forced the decade-old company to quietly shift its focus to a travel management platform for corporate travellers. Now it must face challenges of another kind.
Duroflex wakes up as Wakefit closes in on an IPO
The six-decade old mattress maker files its draft IPO papers just as Wakefit wins approval for a public market debut—setting up a bruising battle for the No. 2 spot.








